Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-012967

EVP, Chief Dev. Officer sold 2,887 shares at $14.83 ($42,818)

From the SEC's structured data for this filing

Trades in this filing

Frenkel Ran · EVP, Chief Dev. Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-18 Sale : show line 1 in the form −2,887 $14.83 $42,818 46,126 D
Open-market sales · 2,887 sh · avg $14.83 · $42,818
Loading xslF345X03/doc4.xml…